Alcon AG

ISIN CH0432492467

 | 

WKN A2PDXE

 

Overview

Description

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.
Show more Show less
Healthcare Healthcare Equipment Other Medical Devices Switzerland

Financials

Key metrics

Market capitalisation, EUR 39,863.16 m
EPS, EUR 1.90
P/B ratio 1.88
P/E ratio 40.88
Dividend yield 0.32%

Income statement (2024)

Revenue, EUR 9,169.36 m
Net income, EUR 941.82 m
Profit margin 10.27%

What ETF is Alcon AG in?

There are 286 ETFs which contain Alcon AG. All of these ETFs are listed in the table below. The ETF with the largest weighting of Alcon AG is the UBS ETF (CH) MSCI Switzerland IMI Socially Responsible (CHF) A-dis.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.